Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 10, 1996, Pages 685-692

  Gronneberg R ^a   Baud, J ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anti IgE; Late cutaneous reaction; Salmeterol; Skin; Terbutaline; Wheal and flare reaction; Adrenoceptor agonist

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E; SALMETEROL; TERBUTALINE;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRADERMAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN INFLAMMATION; SKIN TEST;

EID: 0029836572     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04448.x     Document Type: Article

References (33)

1. Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 1991;104:672-6.
2. Erjefält I, Persson CGA. Pharmacologic control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991;143:1008-14.
3. 2-adrenoceptor agonist in guinea pig skin. Eur J Pharmacol 1995;272:185-93.
4. Whelan CJ, Johnson M, Vardey CJ. Comparison of the antiinflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br J Pharmacol 1993;110:613-18.
5. 2-adrenergic agonist formoterol. J Appl Physiol 1994;77:397-405.
6. Whelan CJ, Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol 1992;105:831-8.
7. Anderson GP. Pharmacology of formoterol: an innovative bronchodilator. New drugs for asthma therapy. Agents Actions 1991;34:97-115.
8. Johnson M, Butchers PR, Coleman RA, et al. The pharmacology of salmeterol. Life Sci 1993;52:2131-43.
9. 2-agonist. J Allergy Clin Immunol 1992;89:844-9.
10. Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST. Protection against allergen-induced asthma by salmeterol. Lancet 1990;336:1338-42.
11. Twentyman OP, Finnerty JP, Holgate ST. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma. Am Rev Respir Dis 1991;144:782-7.
12. Wong BJ, Dolovich J, Ramsdale EH, et al. Formoterol compared with beclomethasone and placebo in allergen-induced asthmatic responses. Am Rev Respir Dis 1992;146:1156-60.
13. Niais AT, Ball DI, Butchers PR, et al. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur J Pharmacol 1994;251:127-35.
14. Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994;150:1006-11.
15. Gratziou C, Roberts JA, Walls A, Holgate ST, Howarth P. Lymphocyte population in BAL of asthmatics after salmeterol treatment [Abstract]. Eur Respir J 1992; Suppl 15:207s.
16. Howarth PH. The investigation of the non-bronchodilator properties of asthma therapies in vivo [Abstract]. Eur Respir J 1991; Suppl 14:399S.
17. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
18. Montefort S, Holgate ST, Howarth PH. Review. Leukocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J 1993;6:1044-54.
19. Svensjö E. The hamster cheek pouch as a model in microcirculation research. Eur Respir J 1990; 3 Suppl 12:595s-601s.
20. Grönneberg R, Zetterström O. Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactions. Clin Exp Allergy 1992;21:257-63.
21. 2 antihuman IgE is a universal skin test reagent in the evaluation of skin mast cell degranulation in vivo. J Allergy Clin Immunol 1989;83:1040-8.
22. Gleich GJ. The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol 1982;70:160-9.
23. 2-adrenoceptor agonist, and terbutaline. II. Effect on the late phase reaction. Allergy 1990;45:340-6.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
25. Raud J, Halldén M, Roquet A, et al. Anti-IgE-induced leukocyte recruitment, mediator release, and albumin extravasation in skin-chamber fluid from healthy and atopic subjects. J Allergy Clin Immunol 1996;97:1151-63.
26. 2-adrenergic receptor stimulating compound, on cutaneous responses to histamine. allergen, compound 48/80 and trypsin. Allergy 1979;34:303-9.
27. Shaikh W, Umemoto L, Poothullil J, Hargreave FE, Dolovich J. Relative refractory state for late cutaneous allergic responses. J Allergy Clin Immunol 1977;60:242-6.
28. 2-adrenoceptor agonist, and terbutaline. I. Dose response relation and duration of effect on the early wheal and flare response. Allergy 1990;45:334-9.
29. Grönneberg R, van Hage-Hamsten M, Halldén G, Hed J, Raud J. Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopies. Allergy 1996;51:640-6.
30. 2-Adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. J Appl Physiol 1993;74:1195-9.
31. 3H]-acetylcholine release from the isolated rat and guinea-pig trachea: role of the airway mucosa and prostaglandins. Br J Pharmacol 1994;113:1221-30.
32. Zweiman B. Mediators of allergic inflammation in the skin. Clin Allergy 1988;18:419-33.
33. Pedersen B, Dahl R, Larsen BB, Venge P. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X. Allergy 1993;48:377-82.